 |
|
|
| Poster session 1: Stem Cell Transplantation - Clinical |
| Date: | Friday, 13 June 2003 |
| Time: | 17:00-18:30 |
| Room: | |
| 17:00-18:30 |
0206 |
|
|
HAPLOIDENTICAL T DEPLETED PERIPHERAL BLOOD AND STEM CELL PLUS BONE MARROW TRANSPLANTATION FROM MOTHER TO CHILD WITH THALASSEMIA DISEASE
P. Sodani, P. Polchi, B. Erer, F. Centis, R. Emiliani, C. Giardini, D. Gaziev, S. Stramigioli, F. Agostinelli, M. Andreani, S. Nesci, G. Baldassarri, G. Lucarelli (Pesaro, Italy)
| 17:00-18:30 |
0207 |
|
|
AUTOLOGUS STEM CELL TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOID LEUKAEMIA. RISK FACTORS AT DIAGNOSIS CAN PREDICT THE OUTCOME
A. Candoni, A. Sperotto, V. Tomadini, C. Filì, D. Damiani, R. Fanin (Udine, Italy)
| 17:00-18:30 |
0208 |
|
|
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER A NONMYELOABLATIVE REGIMEN CONTAINING FLUDARABINE, BUSULFAN, AND ATG. SINGLE CENTER EXPERIENCE.
M.D. Doubek, J. Mayer, Z. Koristek, M. Krejci, Y. Brychtova, M. Navratil, I. Vasova, M. Tomiska, I. Buchtova (Brno, Czech Republic)
| 17:00-18:30 |
0209 |
|
|
PULSE CYCLOPHOSPHAMIDE (CP) IN THE TREATMENT OF STEROID-REFRACTORY GVHD
M.D. Doubek, J. Mayer, M. Krejci, A. Oborilova, Y. Brychtova, I. Buchtova (Brno, Czech Republic)
| 17:00-18:30 |
0210 |
|
|
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR EGYPTIAN CHILDREN WITH SEVERE ACQUIRED APLASTIC ANAEMIA
Y. Al-Tonbary, H. Mahmoud, O. Salama, M. Abo Elkheir, M. Sarhan (Mansoura, Egypt)
| 17:00-18:30 |
0211 |
|
|
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RUSSIA. MULTICENTER STUDY
L.P. Mendeleeva, V.G. Savchenko, L.S. Lubimova, V.A. Rossiev, T.S. Konstantinova, T.P. Zagoskina, V.A. Lapin, N.A. Obidina, L.B. Filatov, S.V. Shamansky (Moscow, Russian Federation)
| 17:00-18:30 |
0212 |
|
|
RITUXIMAB IN THE TREATMENT OF CHRONIC EXTENSIVE GRAFT VERSUS HOST DISEASE: CASE REPORT
A. Pivkova, B. Georgievski, L. Cevreska, I. Panovska, Z. Stojanovski, S. Krstevska-Balkanov, D. Efremov (Skopje, Macedonia)
| 17:00-18:30 |
0213 |
|
|
ONE-YEAR CYCLOSPORINE PROPHYLAXIS REDUCES THE RISK OF DEVELOPING EXTENSIVE CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
A. Mengarelli, A.P. Iori, A. Romano, R. Cerretti, L. Cerilli, M.S. De Propris, S. Fenu, M.L. Moleti, L. De Felice, G. Girelli, W. Arcese (Rome, Italy)
| 17:00-18:30 |
0214 |
|
|
CORD BLOOD STEM CELL BANKING AND TRANSPLANTATION
P.S. Dhot, R. Kumar, D. Sirohi, P. Ganguli, D. Swarup, P.C. Chitalkar, V. Nair (New Delhi, India)
| 17:00-18:30 |
0215 |
|
|
THORACOSCOPIC DIAGNOSTIC OF PULMONARY NON-INFECTIOUS COMPLICATIONS IN BONE MARROW RECIPIENTS
K.I. Ntanisian, A. V. Grjimolovski, I.A. Demidova, G.M. Galstian, L.S. Liubimova, V.G. Savchenko, I.I. Owinyi Ochieng (Moscow, Russian Federation)
| 17:00-18:30 |
0216 |
|
|
THE COEXISTENCE OF PLASMOCYTOMA AND CHRONIC MYELOID LEUKAEMIA
A. Kiss, T. Masszi, L. Rejto, Gy. Remenyi, E. Balogh, Sz. Szakall, A. Simon, M. Udvardy (Debrecen, Hungary)
| 17:00-18:30 |
0217 |
|
|
HYPERBARIC OXIGEN TREATMENT FOR REFRACTORY HAEMORRAGIC CYSTITIS AFTER BONE MARROW TRANSPLANTATION
R. Parasole, M. Ripaldi, G. Menna, C. De Fusco, R.M. Infascelli, G. D'Alicandro, V. Poggi (Naples, Italy)
| 17:00-18:30 |
0218 |
|
|
PROFILE OF INFECTIOUS COMPLICATIONS FOLLOWING ALLOGENEIC HLA-IDENTICAL SIBLING TRANSPLANTATION (ALLO-SCT) WITH ANTI-T-LYMPHOCYTE GLOBULIN-BASED REDUCED INTENSITY PREPARATIVE REGIMEN (RIC)
M. Mohty, W. Jacot, C. Faucher, L. Collet, N. Vey, C. Zandotti, K. Bilger, A.M. Stoppa, D. Coso, P. Viens, J.A. Gastaut, D. Maraninchi, D. Blaise (Marseille, France)
| 17:00-18:30 |
0219 |
|
|
IFOSPHAMIDE, EPIRUBICIN, ETOPOSIDE (IEV) AND AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANT: A FEASIBLE AND EFFECTIVE SALVAGE TREATMENT FOR LYMPHOID MALIGNANCIES
C. Venturino, I. Pierri, G.L. Michelis, N. Abdal, V. Galbusera, M. Balocco, A. Garrone, R. Varaldo, F. Ballerini, A. Garuti, M. Clavio, M. Gobbi (Genova, Italy)
| 17:00-18:30 |
0220 |
|
|
NON-MYELOABLATIVE ALLOGENEIC PERIPHERAL BLOOD STEM CELLS TRANSPLANTATION (PBSCT) IS AN EFFECTIVE METHOD OF SALVAGE THERAPY FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
J. Gozdzik, L. Gil, K. Sawinski, M. Kozlowska-Skrzypczak, K. Lewandowski, J. Hansz, M. Komarnicki (Poznan, Poland)
| 17:00-18:30 |
0221 |
|
|
TOTAL PARENTERAL NUTRITION WITH REDUCED CALORIC INTAKE IN BONE MARROW TRANSPLANTATION
T.E. Terruzzi, F. Rossini, M. Bonetti, M. Parma, A. Colaemma, P. Pioltelli, E. Todisco, E.M. Pogliani (Monza, Italy)
| 17:00-18:30 |
0222 |
|
|
BONE MARROW HEMATOPOIESIS IS DEFECTIVE IN THE LATE POST ALLO-SCT PERIOD BUT CORRELATES WITH DONOR'S HEMATOPOIESIS
F.M. Sanchez-Guijo, L.I. Sanchez-Abarca, M.D. Caballero, E. Villaron, C. Pata, L. Vazquez, J.A. Perez Simon, M.C. Del Cañizo, J.F. San Miguel (Salamanca, Spain)
| 17:00-18:30 |
0223 |
|
|
TRANSFUSION FREE ALLOGENEIC STEM CELL TRANSPLANTATION IN A JEHOVA'S WITNESS
T. Zenz, H. Dohner, D. Bunjes (Ulm, Germany)
| 17:00-18:30 |
0224 |
|
|
REASONS FOR NOT CARRYING OUT STEM CELL TRANSPLANTATION (SCT) IN PATIENTS REFERRED TO A TRANSPLANT UNIT
J.M. Sancho, J.M. Ribera, A. Oriol, M. Batlle, M. Torrabadella, L.L. Rodríguez, A. Flores, B. Xicoy, J. Grau, E. Plensa, F. Millá, E. Feliu (Badalona, Spain)
| 17:00-18:30 |
0225 |
|
|
NON-MYELOABLATIVE STEM CELL TRANSPLANTATION (NSCT) IN MDS PATIENTS WITH UNFAVURABLE CHROMOSOME ABERRATIONS
I.A. Demidova, Yu.V. Olshanskaia, L.P. Poreshina, V.G. Savchenko, E.V. Domracheva (Moscow, Russian Federation)
| 17:00-18:30 |
0226 |
|
|
HIGH DOSE SEQUENTIAL FOLLOWED BY AUTOLOGOUS BONE MARROW TRANSPLANTATION IS EFFECTIVE AND SAFE SALVAGE TREATMENT IN ADVANCED HODGKIN'S DISEASE
C.A. De Souza, M.T. Delamain, R.B. Cardoso, K.B. Pagnano, G.B. Oliveira, I. Lorand-Metze, A.C. Vigorito, F.J.P. Aranha, K.A.B. Eid, E.C.M. Miranda, C.A. De Souza (Campinas, Brazil)
| 17:00-18:30 |
0227 |
|
|
BONE MASS IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
J.M. Sancho, S. Holgado, J.M. Ribera, M. Granada, A. Oriol, A. Olivé, M. Valls-Roc, C. Biosca, X. Tena, F. Millá, E. Feliu (Badalona, Spain)
| 17:00-18:30 |
0228 |
|
|
DETECTION OF CHIMERISM AFTER ALLOGENEIC PERIPHERAL BLOOD STEM CELL OR BONE MARROW TRANSPLANTATION BY MULTIPLEX PCR AMPLIFICATION OF SHORT TANDEM REPEAT (STR) GENE LOCI
B. Chahardouli, Y. Mortazavi, S.H. Ghaffari, A. Ghavamzadeh, K. Alimoghaddam, B. Bahar, M. Jahani, M. Iravani, S.A. Mosavi (Tehran, Iran)
| 17:00-18:30 |
0229 |
|
|
A PHENOTYPIC STUDY OF NATURAL KILLER RECEPTOR (NKR) AND PEN-5 (CD162R) EXPRESSION ON IMMUNE EFFECTORS PRESENT IN ALLOGENEIC HEMATOPOIETIC CELL PRODUCTS
F. Lassailly, T. Alario, V. Pascal, P. Andre, F. Romagne, P. Paul, D. Blaise, E. Vivier, C. Chabannon (Marseille Cedex9, France)
| 17:00-18:30 |
0230 |
|
|
HUMAN HERPESVIRUS-6 AND -7 ANTIGENEMIA AND THE ASSOCIATION TO CYTOMEGALOVIRUS VIREMIA IN ADULT ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS
L. Volin, I. Lautenschlager, E. Juvonen, V-J. Anttila, T. Ruutu (Helsinki, Finland)
| 17:00-18:30 |
0231 |
|
|
EARLY AND LATE COMPLICATIONS AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (PBSCT): SINGLE CENTRE EXPERIENCE
N. Tsvyetkova, I. Kryachok, J. Minchenko, E. Karamanesht, I. Koren'kova, S. Borodkin, N. Kostyukova, E. Koucher, S. Tsyva, V. Khomenko, V. Bebeshko (Kiev, Ukraine)
| 17:00-18:30 |
0232 |
|
|
LIMITED AUTOLOGOUS BLOOD STEM CELL RESCUE TO SUPPORT SUCCESSIVE COURSES OF HIGH-DOSE (HD) ARA-C IN AML: COMPARATIVE ANALYSIS OF TOXICITY BY CELL DOSE
E.M. Pogliani, G. Rossi, P. Fabris, F. Marmont, T. Chisesi, P. Coser, A. Porcellini, M. Musso, E. Terruzzi, E. Borlenghi, E. Oldani, E. Gallo, P. Coser, T. Barbui, R. Bassan (Monza, Italy)
| 17:00-18:30 |
0233 |
|
|
DYNAMICS OF MINIMAL RESIDUAL DISEASE AND CHIMERISM AFTER NONMYELOABLATIVE AND MYELOABLATIVE STEM CELL TRANSPLANTATIONS FOR CHRONIC MYELOID LEUKEMIA
Y. Brychtova, M. Doubek, J. Pacholíkova, T. Freiberger, M. Krejci, O. Horky, J. Mayer (Brno, Czech Republic)
| 17:00-18:30 |
0234 |
|
|
QUALITY OF LIFE AS A NEW PARADIGM TO ASSESS OUTCOMES OF HIGH DOSE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
Ju.L. Shevchenko, A. Novik, T. Ionova, V. Melnichenko, S. Voloshin, I. Rykov, N. Osipova (Moscow, Russian Federation)
| 17:00-18:30 |
0235 |
|
|
INFLUENCE OF MYELOMA CELLS FREQUENCY IN BONE MARROW BEFORE
AUTO-PBSCT AND LEUKAPHERESIS PRODUCT ON SURVIVAL TIME IN PATIENTS WITH MULTIPLE MYELOMA
M.E. Feliksbrot, M.A. Krol, M. Paluszewska, E. Czuba, E. Urbanowska, E. Graczyk-Pol, W.W. Jedrzejczak, J. Dwilewicz-Trojaczek (Warsaw, Poland)
| 17:00-18:30 |
0236 |
|
|
2'DCF AND HEMATOPOIETIC STEM CELLS TRANSPLANTATION (HSCT) FOR RESISTANT LANGERHANS CELL HISTIOCYTOSIS (LCH)
G. De Rossi, A. Lombardi, M. Caniglia, R.M. Pinto, V. Coletti, M.B. Pinazzi, I. Rana (Rome, Italy)
| 17:00-18:30 |
0237 |
|
|
HAEMATOPOIETIC PROGENITOR CELLS DETERMINATION BY AN AUTOMATED HAEMATOLOGY ANALYSER DURING MOBILIZATION PROCESS
H.Z.W. Grotto, J.F.A. Noronha, A.R.C. Reis (Campinas, Brazil)
| 17:00-18:30 |
0238 |
|
|
DONOR T-CELL AND STEM CELL SUPPORT COMBINED WITH CHEMOTHERAPY IN A CHILD WITH HIGH RISK AML AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AT THE BEGINNING OF RELAPSE
S. Weigel, S. Mukodzi, P. Bader, J.F. Beck (Greifswald, Germany)
| 17:00-18:30 |
0239 |
|
|
SIDE EFFECTS OF DIMETHYL SULFOXIDE (DMSO) INFUSION DURING PERIPHERAL BLOOD STEM CELL TRANSPLANTATIONS (PBSCT)
A. Ugur-Bilgin, I. Karadogan, B. Avci, R. Oren, F. Gencay-Yilmaz, F. Erkan, A. Timuragaoglu, E. Kurtoglu, L. Undar (Antalya, Turkey)
| 17:00-18:30 |
0240 |
|
|
A SINGLE - CENTRE STUDY IN 102 PATIENTS USING THE CLINIMACS DEVICE FOR CD34 CELL SELECTION OF ALLOGENEIC PERIPHERAL BLOOD PROGENITOR CELLS
M.R. Ringhoffer, M. Wiesneth, S.V. Harsdorf, R.F. Schlenk, A. Schmitt, P.P. Reinhadt, M. Moessner, W. Grimminger, P. Schauwecker, H. Wilts, T. Mertens, D. Dohr, S.N. Reske, H. Döhner, D. Bunjes (Ulm, Germany)
| 17:00-18:30 |
0241 |
|
|
DIFFUSE LARGE B CELL LYMPHOMA OF BONES - CHEMIOTHERAPY AND IMMUNOTHERAPHY WITH RITUXIMAB CONSOLIDATED BY AUTOLOGOUS STEM CELL TRANSPLANT
W. Jurczak, A. Zaluska, D. Krochmalczyk, Z. Rudzki, A. Wywial, M. Pasowicz, A.B. Skotnicki (Kraków, Poland)
| 17:00-18:30 |
0242 |
|
|
FEASIBILITY AND TOXICITY OF TANDEM HIGH-DOSE THERAPY WITH PERIPHERAL BLOOD STEM CELLS TRANSPLANTATION (PBSCT) FOR PATIENTS WITH LYMPHOMAS
M. Magagnoli, M. Balzarotti, L. Castagna, A. Nozza, I. Timofeeva, S. Compasso, L. Siracusano, B. Sarina, A. Santoro (Rozzano (milano), Italy)
| 17:00-18:30 |
0243 |
|
|
TREATMENT OF B-CELL PROLYMPHOCYTIC LEUKAEMIA WITH AUTOGRAFTING, FOLLOWING CONDITIONING WHICH INCLUDED ALEMTUZUMAB
M. Eibl, H.W. Auner, W. Linkesch (Graz, Austria)
| 17:00-18:30 |
0244 |
|
|
A SINGLE CENTER EXPERIENCE OF AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA
M. Tarabar, D. Stamatovic, Lj. Tukic, L. Ristic, V. Glavicic, M. Mijuskovic, B. Balint, M. Malesevic (Belgrade, Yugoslavia)
| 17:00-18:30 |
0245 |
|
|
NON-MYELOABLATIVE STEM CELL TRANSPLANTATION (NST) IN THE TREATMENT OF ADVANCED HEMATOLOGICAL MALIGNANCIES
M. Malesevic, D. Stamatovic, B. Balint, M. Vlahovic, S. Marijanovic, Lj. Simic, B. Torodic-Zivanovic, V. Glavicic, S. Milicevic (Belgrade, Yugoslavia)
| 17:00-18:30 |
0246 |
|
|
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA - A 12 YEAR SINGLE CENTRE EXPERIENCE
A.D. Wechalekar, K.H. Orchard, A.S. Duncombe, D. Teal, A.G. Smith (Southampton, United Kingdom)
| 17:00-18:30 |
0247 |
|
|
THE INFLUENCE OF CD34-CELL DOSE ON OUTCOME AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
J. Holowiecki, S. Giebel, M. Krawczyk-Kulis, J. Wojnar, B. Stella-Holowiecka, M. Wojciechowska, L. Kachel, T. Kruzel, S. Grosicki, T. Czerw (Katowice, Poland)
| 17:00-18:30 |
0248 |
|
|
DEVELOPMENT OF IMMUNE TOLERANCE TO FORMED DE NOVO ERYTHROCYTES OF RECIPIENTS ABO-MISMATCHED HEMATOPOIETIC STEM CELL TRANSPLANTATION
A.E. Kalmykova (Minsk, Republic of Belarus)
| 17:00-18:30 |
0249 |
|
|
THALIDOMIDE AS A MAINTENANCE THERAPY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
L. Gil, D. Drozdowska, A. Czyz, J. Gozdzik, J. Hansz, M. Komarnicki (Poznan, Poland)
| 17:00-18:30 |
0250 |
|
|
ALLOGENEIC STEM CELL TRANSPLANTATION WITH REDUCED INTENSITY CONDITIONING REGIMEN IN PATIENTS WITH REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA- A SINGLE CENTRE EXPERIENCE
L. Gil, A. Czyz, J. Gozdzik, M. Kozlowska, K. Sawinski, J. Parulska, J. Hansz, M. Komarnicki (Poznan, Poland)
| 17:00-18:30 |
0251 |
|
|
A RANDOMIZED, DOUBLE-BLIND COMPARATIVE STUDY OF PARENTERAL NUTRITIONAL SUPPORT WITH OR WITHOUT GLUTAMINE IN AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR NON-HODGKIN'S LYMPHOMA AND MULTIPLE MYELOMA
A.P. Poznarova, J. Horacek, P. Zak, M. Kmonicek, J. Maly (Hradec Kralove, Czech Republic)
| 17:00-18:30 |
0252 |
|
|
INCIDENCE OF MICROBIOLOGICALLY DOCUMENTED INFECTIONS IN PATIENS WITH MYELOMA UNDERGOING PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN A SINGLE CENTER
N. Fernandez Mosteirin, C. Salvador-Osuna, D. Rubio, J.J. Gimeno, E. Orna, P. Mayayo, P. Giraldo, M. Giralt (Zaragoza, Spain)
| 17:00-18:30 |
0253 |
|
|
TREATMENT OF HODGKIN'S DISEASE WITH AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): ANALYSIS OF RESULTS AND PROGNOSTIC FACTORS IN 341 PATIENTS FROM THE POLISH LYMPHOMA RESEARCH GROUP
J. Czyz, R. Dziadziuszko, W. Knopinska-Posluszny, A. Hellmann, L. Kachel, J. Holowiecki, J. Gozdzik, J. Hansz, A. Avigdor, A. Nagler, M. Osowiecki, J. Walewski, P. Mensah, W. Jurczak, A. Skotnicki (Gdansk, Poland)
| 17:00-18:30 |
0254 |
|
|
DENDRITIC CELL RECOVERY AFTER ALLOGENIC STEM CELL TRANSPLANTATION IN ACUTE LEUKEMIA: CORRELATIONS WITH PATIENTS AND TRANSPLANT CHARACTERISTICS
M. Della Porta, G.M. Rigolin, E.P. Alessandrino, M. Maiocchi, L. Malcovati, L. Vanelli, C. Baratè, E. Rumi, M. Lazzarino, G. Castoldi (Ferrara, Italy)
| 17:00-18:30 |
0255 |
|
|
'ANTIBIOTIC PROPHYLAXIS WITH MEROPENEM AFTER ALLOGENEIC STEM CELL TRANSPLANTATION'
I. García-Escobar, J.A. Pérez-Simón, J. Martinez, L. Vazquez, D. Caballero, C. Cañizo, J.F. San Miguel (Salamanca, Spain)
| 17:00-18:30 |
0256 |
|
|
CLINICAL EVIDENCES OF COMPLEMENT MONITORIZATION DURING THE AUTOLOGOUS STEM CELL TRANSPLANTATION OF PATIENTS WITH MALIGNANT LYMPHOMAS
A. Banyai, K. Paloczi, A. Barta, L. Gopcsa, A. Sandil, L. Varga (Budapest, Hungary)
| 17:00-18:30 |
0257 |
|
|
NON MYELOABLATIVE TRANSPLANT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PROSPECTIVE MULTICENTER TRIAL
M.D. Caballero, R. Martino, A. Leon, A. Urbano, G. Sanz, J. Sarrá, J.A. Pérez-Simón, C. Canals, M.V. Mateos, A. Sureda, J. Sierra, J.F. San Miguel (Salamanca, Spain)
| 17:00-18:30 |
0258 |
|
|
EX VIVO T-CELL DEPLETION BY EXPOSURE TO CAMPATH MONOCLONAL ANTIBODIES IN HAEMATOPOIETIC STEM CELL ALLOGRAFTING: AT FIFTEEN YEARS SINGLE TEAM EXPERIENCE
P. Jacobs, L. Wood, H. Waldman, G. Hale (Plumstead, South Africa)
| 17:00-18:30 |
0259 |
|
|
ENOXAPARIN CAN BE USED SAFELY IN PATIENTS WITH SEVERE THROMBOCYTOPENIA DUE TO INTENSIVE CHEMOTHERAPY REGIMENS
Y. Herishanu, M. Misgav, O. Goor, I. Kirgner, O. Ben-Tal, E. Naparstek (Tel-aviv, Israel)
| 17:00-18:30 |
0260 |
|
|
GOOD AND POOR MOBILIZERS IN ACUTE LEUKEMIA PATIENTS: ANALYSIS OF FACTORS AFFECTING THE YIELD
D. Pastore, G. Specchia, A. Mestice, P. Carluccio, A. Pannunzio, G. Greco, L. Ciuffreda, S. Sibilla, V. Liso (Bari, Italy)
| 17:00-18:30 |
0261 |
|
|
LONG-TERM EVENT FREE SURVIVAL (>= 5 YEARS) IN PATIENTS WITH MYELOMA PLANNED TO RECEIVE A SINGLE AUTOTRANSPLANT : COMPARABLE RESULTS COMPARED TO TANDEM AUTOTRANSPLANTS
B. Sirohi, R. Powles, J. Mehta, S. Kulkarni, C. Horton, R. Saso, S. Singhal (Sutton, United Kingdom)
| 17:00-18:30 |
0262 |
|
|
LONG-TERM MOLECULAR FOLLOW-UP IN INDOLENT LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOGRAFTING: DURABLE CLINICAL AND MOLECULAR REMISSIONS CAN BE ACHIEVED ONLY IN FOLLICULAR SUBTYPES
P. Corradini, M. Ladetto, F. Zallio, M. Astolfi, E. Rizzo, S. Sametti, F. Benedetti, U. Vitolo, D. Caracciolo, C. Voena, M. Boccadoro, A. Pileri, C. Tarella (Milano, Italy)
| 17:00-18:30 |
0263 |
|
|
REDICTIVE MODEL BASED ON DAY 7 PARAMETERS TO PREDICT THE RISK OF TREATMENT
RELATED MORTALITY (TRM) IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOETIC-STEM
CELL TRANSPLANT (AHSCT)
R. Powles, S. Kulkarni, B. Sirohi, J. Mehta, C. Horton, S. Singhal (Sutton, United Kingdom)
| 17:00-18:30 |
0264 |
|
|
REDUCED-INTENSITY CONDITIONING FOLLOWED BY ALLOGENEIC TRANSPLANTATION CAN PRODUCE DURABLE CLINICAL AND MOLECULAR REMISSIONS IN RELAPSED NON-HODGKIN LYMPHOMAS
P. Corradini, M. Bregni, C. Tarella, A. Olivieri, A. Dodero, L. Farina, F. Zallio, P. Leoni, F. Ciceri, F. Benedetti, E. Pogliani, A. Rambaldi, A. Locasciulli, R. Scime, A.M. Gianni (Milano, Italy)
| 17:00-18:30 |
0265 |
|
|
DONOR LYMPHOCYTE INFUSIONS AFTER RELATED AND UNRELATED HEMATOPOIETIC CELL TRANSPLANTATIONS
M. Stadler, L. Hambach, S. Buchholz, A. Franzke, H. Diedrich, E. Dammann, M. Eder, A. Ganser, B. Hertenstein (Hannover, Germany)
| 17:00-18:30 |
0266 |
|
|
RECONSTITUTION OF T-CELLS AND NK-CELLS AFTER HEMATOPOIETIC CELLS TRANSPLANTATION (HSCT)
P. Boguradzki, G. Charlinski, A. Deptała, J. Dwilewicz-Trojaczek, M. Król, M. Paluszewska, M. Rokicka, M. Tormanowska, E. Urbanowska, W. Jedrzejczak (Warsaw, Poland)
|